KARD (Kardigan) Days Inventory: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KARD Kardigan Inc KARD
12 GF Score
Price $16.64
! 1 Warning Sign
View Full Analysis

What is Kardigan Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Kardigan's Average Total Inventories for the three months ended in Jun. 2026 was $0.00 Mil. Kardigan's Cost of Goods Sold for the three months ended in Jun. 2026 was $2.19 Mil. Hence, Kardigan's Days Inventory for the three months ended in Jun. 2026 was 0.00.

The historical rank and industry rank for Kardigan's Days Inventory or its related term are showing as below:

KARD's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 184.675
* Ranked among companies with meaningful Days Inventory only.

Kardigan's Days Inventory stayed the same from . 20 (0.00) to Jun. 2026 ().

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Kardigan  (NAS:KARD) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Kardigan's Inventory Turnover for the three months ended in Jun. 2026 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Kardigan's Inventory to Revenue for the three months ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Kardigan Days Inventory Related Terms


Kardigan Days Inventory Historical Data

* Premium members only.

The historical data trend for Kardigan's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kardigan Days Inventory Chart

Kardigan Annual Data
Trend Dec24 Dec25
Days Inventory

Kardigan Quarterly Data
Mar25 Jun25 Mar26 Jun26
Days Inventory

KARD vs TSHA, VIR, GHRS: Days Inventory Comparison

For the Biotechnology subindustry, Kardigan's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kardigan Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kardigan's Days Inventory distribution charts can be found below:

* The bar in red indicates where Kardigan's Days Inventory falls into.


KARD
12GF Score
Kardigan Inc KARD
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kardigan Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Kardigan's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 5.743*365
=0 / 5.743*365
=0.00

Kardigan's Days Inventory for the quarter that ended in Jun. 2026 is calculated as:

Days Inventory (Q: Jun. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Mar. 2026 ) + Total Inventories (Q: Jun. 2026 )) / count ) / Cost of Goods Sold (Q: Jun. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 2.19*365 / 4
=0 / 2.19*365 / 4
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kardigan Business Description

Address 506 Carnegie Center Drive, Suite 201, Princeton, NJ, USA, 08540
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
12GF Score

Get the complete analysis for KARD

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.64
Price